Molly Henderson
Financieel Directeur/CFO bij PHATHOM PHARMACEUTICALS, INC.
Vermogen: 884 283 $ op 30-04-2024
Actieve functies van Molly Henderson
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
PHATHOM PHARMACEUTICALS, INC. | Comptroller/Controller/Auditor | 05-04-2022 | - |
Financieel Directeur/CFO | 05-04-2022 | - |
Loopbaan van Molly Henderson
Eerdere bekende functies van Molly Henderson
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
CALLIDITAS THERAPEUTICS AB | Directeur/Bestuurslid | 25-06-2020 | 30-05-2023 |
Independent Dir/Board Member | - | 30-05-2023 | |
UROGEN PHARMA LTD. | Comptroller/Controller/Auditor | 01-10-2020 | 25-03-2022 |
Financieel Directeur/CFO | 01-10-2020 | 25-03-2022 | |
AYALA PHARMACEUTICALS, INC. | Financieel Directeur/CFO | 06-06-2018 | 25-09-2020 |
IOVANCE BIOTHERAPEUTICS, INC. | Financieel Directeur/CFO | 08-06-2015 | 01-08-2016 |
Investor Relations Contact | 08-06-2015 | 01-08-2016 | |
VIRTUALSCOPICS INC | Financieel Directeur/CFO | 01-05-2003 | 31-08-2013 |
Bedrijfssecretaris | 02-11-2009 | 31-08-2013 | |
ULTRALIFE CORPORATION | Comptroller/Controller/Auditor | 01-08-2000 | 01-08-2002 |
PricewaterhouseCoopers LLP
PricewaterhouseCoopers LLP Miscellaneous Commercial ServicesCommercial Services PricewaterhouseCoopers LLC provides assurance, tax and advisory services. Its services include audit and assurance, consulting, deals, human resources, legal, tax, and family business. The firm also offers accountability, risk management, structuring, mergers and acquisitions, and performance and process improvement. The company was founded in 1998 and is headquartered in Buffalo, NY. | Comptroller/Controller/Auditor | - | - |
Opleiding van Molly Henderson
State University of New York at Buffalo | Graduate Degree |
Statistieken
Internationaal
Verenigde Staten | 8 |
Verenigd Koninkrijk | 2 |
Zweden | 2 |
Operationeel
Director of Finance/CFO | 5 |
Comptroller/Controller/Auditor | 4 |
Corporate Secretary | 1 |
Sectoraal
Health Technology | 6 |
Commercial Services | 3 |
Producer Manufacturing | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 5 |
---|---|
ULTRALIFE CORPORATION | Producer Manufacturing |
IOVANCE BIOTHERAPEUTICS, INC. | Health Technology |
CALLIDITAS THERAPEUTICS AB | Health Technology |
UROGEN PHARMA LTD. | Health Technology |
PHATHOM PHARMACEUTICALS, INC. | Health Technology |
Bedrijven in privébezit | 3 |
---|---|
PricewaterhouseCoopers LLP
PricewaterhouseCoopers LLP Miscellaneous Commercial ServicesCommercial Services PricewaterhouseCoopers LLC provides assurance, tax and advisory services. Its services include audit and assurance, consulting, deals, human resources, legal, tax, and family business. The firm also offers accountability, risk management, structuring, mergers and acquisitions, and performance and process improvement. The company was founded in 1998 and is headquartered in Buffalo, NY. | Commercial Services |
VirtualScopics, Inc.
VirtualScopics, Inc. Miscellaneous Commercial ServicesCommercial Services VirtualScopics, Inc. provides quantitative imaging solutions currently serving the pharmaceutical, biotechnology and medical device industries. It provides image analysis software tools and applications which are used in detecting and measuring specific anatomical structures and metabolic activity using medical images. The company's therapeutic area expertise includes oncology, rheumatoid arthritis, osteoarthritis, neurology, cardiovascular, muscle and fat measurements and COPD studies utilizing MRI, PET, CT, Ultrasound and X-Ray imaging modalities. VirtualScopics was founded by Saara Totterman, Kevin J. Parker, Jose Tamez-Pena and Edward Ashton in July 2000 and is headquartered in Rochester, NY. | Commercial Services |
Advaxis, Inc.
Advaxis, Inc. Pharmaceuticals: MajorHealth Technology Advaxis, Inc. is a biotechnology company, which engages in the discovery, development and commercialization of cancer immunotherapies. It manages platform technology that utilizes live attenuated Listeria monocytogenes bioengineered to secrete antigen or adjuvant fusion proteins. The firm has four franchises in various stages of clinical and pre-clinical development, namely: HPV-associated cancers, prostate cancer, neoantigen therapy and hotspot mutation therapy. The company was founded on June 5, 1987 and is headquartered in Princeton, NJ. | Health Technology |
- Beurs
- Insiders
- Molly Henderson
- Ervaring